Related Experiment Video
Updated: Jan 26, 2026

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
Published on: November 3, 2020
CRISPR/Cas9 engineering of ERK5 identifies its FAK/PYK2 dependent role in adhesion-mediated cell survival
Moazzam Ali1, Zeeshan Mutahir1, Anjum Riaz1
1Institute of Biochemistry and Biotechnology, University of the Punjab, 54590, Lahore, Pakistan.
Abstract:
Extracellular signal-regulated kinase 5 (ERK5) is now considered a key regulator of breast cancer cell proliferation, migration and invasion. It is also implicated in growth factor induced anti-apoptotic signaling. But its contribution to adhesion-induced survival signaling is not clear. In the present study, using CRISPR/Cas9 editing, we knocked-out ERK5 expression in several cancer cell lines. Then MDA-MB 231 breast cancer cells lacking ERK5 were used to understand its role in adhesion-mediated cell viability. We demonstrated that ERK5 deficient cells exhibited reduced cell attachment to matrix proteins fibronectin and vitronectin. The adhesion ability of these cells was further reduced upon chemical inhibition of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) by PF 431396. FAK/PYK2 inhibited ERK5 knock-out cells also showed markedly reduced cell-viability and increased apoptotic signaling. This was evident from the detection of cleaved PARP and caspase 9 in these cells. Thus, our data suggests a FAK/PYK2 regulated pro-survival role of ERK5 in response to cell adhesion.
Insights
Extracellular signal-regulated kinase 5 (ERK5) is crucial for breast cancer cell survival and adhesion. Its absence, particularly when focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) are inhibited, significantly reduces cell viability and increases apoptosis.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Signaling Pathways
Background:
- Extracellular signal-regulated kinase 5 (ERK5) is recognized for its role in breast cancer cell proliferation, migration, and invasion.
- ERK5 is also involved in anti-apoptotic signaling pathways induced by growth factors.
- The specific contribution of ERK5 to adhesion-induced survival signaling remains unclear.
Purpose of the Study:
- To investigate the role of ERK5 in adhesion-mediated cell viability in breast cancer.
- To elucidate the signaling pathways involving ERK5, focal adhesion kinase (FAK), and proline-rich tyrosine kinase 2 (PYK2) in cell survival.
Main Methods:
- CRISPR/Cas9 gene editing was employed to knock out ERK5 expression in cancer cell lines.
- MDA-MB 231 breast cancer cells lacking ERK5 were utilized to assess adhesion-mediated cell viability.
- Chemical inhibition of FAK and PYK2 using PF 431396 was performed.
Main Results:
- ERK5-deficient cells showed reduced attachment to extracellular matrix proteins fibronectin and vitronectin.
- Combined ERK5 knockout and FAK/PYK2 inhibition led to further decreased cell adhesion.
- These cells exhibited significantly reduced cell viability and increased apoptosis, indicated by cleaved PARP and caspase 9 detection.
Conclusions:
- ERK5 plays a pro-survival role in response to cell adhesion in breast cancer cells.
- This pro-survival function of ERK5 is regulated by focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2).
- Targeting ERK5 in combination with FAK/PYK2 inhibition may represent a therapeutic strategy for breast cancer.
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
What is Genetic Engineering?
CRISPR/Cas9 Genome Editing
Adhesion
Capillary action is a result of water’s adhesive tendencies. When a narrow...
Cell Adhesion in Plants
Pectins are complex heteropolymers mainly composed of negatively-charged α-D-glucopyranosyl uronic acid and some neutral glycosyl residues such as α-L-rhamnopyranose, α-L-arabinofuranose,...

